In Vitro Metabolism Considerations, Including Activity Testing of Metabolites, in the Discovery and Selection of the COX-2 Inhibitor Etoricoxib (MK-0663) - Chauret, N; Yergey, J A; Brideau, C (Bioorg Med Chem Lett, 2001)
et al.